A detailed history of Legacy Advisors, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Legacy Advisors, LLC holds 11,518 shares of ZTS stock, worth $2.01 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares
11,518
Previous 3,266 252.66%
Holding current value
$2.01 Million
Previous $644,000 202.48%
% of portfolio
0.25%
Previous 0.08%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024

BUY
$165.67 - $199.94 $1.37 Million - $1.65 Million
8,252 Added 252.66%
11,518 $1.95 Million
Q4 2023

Feb 12, 2024

BUY
$151.44 - $200.09 $10,449 - $13,806
69 Added 2.16%
3,266 $644,000
Q3 2023

Nov 14, 2023

BUY
$167.14 - $192.77 $13,538 - $15,614
81 Added 2.6%
3,197 $556,000
Q2 2023

Jul 20, 2023

BUY
$160.94 - $186.23 $501,489 - $580,292
3,116 New
3,116 $536,000
Q4 2017

Jan 26, 2018

SELL
$63.24 - $72.8 $3,857 - $4,440
-61 Closed
0 $0
Q3 2017

Nov 03, 2017

BUY
$59.73 - $65.4 $3,643 - $3,989
61
61 $3,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $81.8B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Legacy Advisors, LLC Portfolio

Follow Legacy Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legacy Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Legacy Advisors, LLC with notifications on news.